Business Insider

New Two-Year Data at the 24th World Congress of Dermatology Shows SKYRIZI™ (risankizumab) Maintains Complete Skin Clearance

NORTH CHICAGO, Ill., June 11, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new results showing a significant number of patients treated ...
Reuters

Abbvie Says Data Shows Skyrizi Achieves Superior Rates Of Complete Skin Clearance Vs Cosentyx At 52 Weeks

* ABBVIE INC - NEW HEAD-TO-HEAD DATA FROM IMMERGE PHASE 3B OPEN-LABEL STUDY SHOW SKYRIZI DEMONSTRATED SUPERIORITY TO COSENTYX AT WEEK 52 * ABBVIE INC - NO NEW SAFETY SIGNALS WERE OBSERVED FOR SKYRIZI ...
WebMD

How Skyrizi Works for Plaque Psoriasis

Although many people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin, some people with moderate or severe plaque psoriasis do not get enough ...
Healio

Skyrizi snags FDA approval for moderate to severe UC; first IL-23 approved for UC, CD

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Skyrizi for the treatment of adult patients with moderate to severe ulcerative colitis, ...
Reuters

J&J's oral psoriasis drug helps patients achieve clear skin in late-stage study

May 9 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Friday its experimental psoriasis drug met the main goal of a late-stage study, as the once-daily pill helped patients achieve clear ...